相关实验视频

Updated: May 20, 2025

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

High Resolution Electron Microscopy of the Helicobacter pylori Cag Type IV Secretion System Pili Produced in Varying Conditions of Iron Availability

Published on: November 21, 2014

由病原体Helicobacter pylori诱导的聚胺代谢的改变:对胃炎症和致癌性的影响

Alain P Gobert¹, Caroline V Hawkins², Kara M McNamara³

¹Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, United States; Center for Mucosal Inflammation and Cancer, Vanderbilt University Medical Center, Nashville, TN, United States; Program in Cancer Biology, Vanderbilt University Medical Center, Nashville, TN, United States.

Methods in enzymology

|May 17, 2025

概括

杆菌感染导致胃炎症和癌症风险. 精子氧化酶衍生的阿克罗莱因在这种进展中起着关键作用,突出了一个新的治疗点.

科学领域:

胃肠病学胃肠病学
在瘤学瘤学.
微生物学微生物学

背景情况:

杆菌感染影响全球一半的人口,导致慢性炎症和增加胃癌风险.
多氨酸及其代谢失调与H. pylori相关的胃疾病的发病有关.
一种反应性化物阿克罗莱因已被确定为H. pylori感染进展的关键调解剂.

研究的目的:

阐明精氨酸氧化酶衍生的烯蛋白在H.pylori感染的发病过程中的作用.
调查阿克罗莱因生成与胃炎和瘤转变的进展之间的联系.
详细介绍研究H. pylori感染和阿克罗莱因生产的实验方法.

主要方法:

在体外培养Helicobacter pylori.
使用动物实验对象的体内感染模型.
使用胃器官的体外感染模型.
评估阿克罗莱因生成及其生物学影响.

主要成果:

聚胺通路的失调,特别是烯蛋白的产生,是H. pylori诱导的胃炎症的一个重要因素.
来自精氨酸氧化酶活性的阿克罗莱因对H. pylori感染向胃癌的进展至关重要.
实验模型成功地证明了H. pylori,acrolein和癌症发展之间的联系.

结论:

精子氧化酶衍生的烯蛋白是H. pylori感染的关键病原性因素,导致炎症和癌症.
准聚胺通路和阿克罗莱因生成为预防与H. pylori相关的胃癌提供了潜在的策略.
描述的方法为进一步研究H. pylori病原和治疗干预提供了框架.

关键词:

亚克罗莱因是一种蛋白质.胃癌是什么?胃癌是什么?胃炎是一种胃炎.在Helicobacter Pylori的研究中,聚胺是一种聚胺.

更多相关视频

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode

Published on: June 18, 2016

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration

Mouse- and Human-derived Primary Gastric Epithelial Monolayer Culture for the Study of Regeneration

Published on: May 7, 2018

相关概念视频

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...

Gastritis-II: Pathophysiology

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.